ARS Pharmaceuticals announces agreement with ALK to commercialize neffy

By Yahoo! Finance   |   2 years ago
ARS Pharmaceuticals announces agreement with ALK to commercialize neffy

ARS Pharmaceuticals has entered a licensing agreement with ALK-Abello A/S for the exclusive commercialization of neffy in Europe, Canada, and other regions outside the U.S. ARS Pharma will retain neffy rights in the U.S.

Read More

Did you find this insightful?